Garuda Therapeutics Funding: $72M Raised, Series A (2023)
Garuda Therapeutics has raised $72M in total funding. Latest round: Series A. Backed by Aisling Capital, Northpond Ventures, Orbimed.
Garuda Therapeutics funding overview
Garuda Therapeutics has raised $72M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series A announced in January 2023. The round record for Garuda Therapeutics runs through 2023; nothing later has been disclosed. Investors on record include Aisling Capital, Northpond Ventures, Orbimed. 3 distinct backers are named across the disclosed rounds.
Garuda Therapeutics at a glance
Total raised
$72M
Latest round
Series A
Latest round date
January 2023
Notable investors
Aisling Capital, Northpond Ventures, Orbimed
Frequently asked about Garuda Therapeutics funding
How much has Garuda Therapeutics raised?
Garuda Therapeutics has raised $72M in total disclosed funding across the rounds on record.
Who has invested in Garuda Therapeutics?
Aisling Capital, Northpond Ventures, Orbimed are named among the investors backing Garuda Therapeutics.
What was the latest Garuda Therapeutics funding round?
The most recent disclosed round is a Series A, announced in January 2023.
Where is Garuda Therapeutics based?
No headquarters location is disclosed for Garuda Therapeutics.
When did Garuda Therapeutics last raise?
The last disclosed Garuda Therapeutics round closed in January 2023 at Series A.
Totals shown for Garuda Therapeutics aggregate every disclosed round on file. To see how that compares, browse the companies and the investors behind them below.
